Search Results 901-910 of 15993 for anti-TNF drugs

1. Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma - Mayo Clinic

   Clinical Trials · Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · More about research at Mayo Clinic.

2. Netupitant and palonosetron (oral route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Kidney Tumors Clinical Trials - Mayo Clinic Research

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab ... anti-cancer drug. The antibody is used to recognize tumor cells so the anti ...

4. A Study to Compare Elacestrant vs. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Any investigational anti-cancer drug therapy < 28 days or five half-lives ...

5. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   About this study. To evaluate the effectiveness of NY-ESO-1-Specific (c259) T Cells, alone or in combination with other anti-cancer agents, in HLA-A*02:01, ...

6. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   ... treatment in spite of adequate anti-infective therapy; Autologous or allogeneic bone marrow transplant as second-line therapy. Pregnant or lactating females ...

7. Acute lymphocytic leukemia - Diagnosis and treatment - Mayo Clinic

   Treatment · Chemotherapy. Chemotherapy, which uses drugs to kill cancer cells, is typically used as an induction therapy for children and adults with acute ...

8. Mayo Clinic researchers clarify chemo resistance, and perhaps a new therapy

   ROCHESTER, Minn. — Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool.

9. Tumors And Masses Clinical Trials - Mayo Clinic Research

   ... drug to provoke an immune response (immunogenicity) and anti-tumor activity of MCLA-128 in patients with solid tumors harboring an NRG1 fusion. A Study of ...

10. Mayo Clinic researchers identify therapy that shrinks tumors in patients with multiple myeloma

    PHOENIX – Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients ...